Association Between Apolipoprotein E Polymorphism and Subclinic Atherosclerosis in Patients with Type 1 Diabetes Mellitus

Atabek, Mehmet; Özkul, YUSUF; Eklioglu, Beray; Kurtoglu, Selim; Baykara, Murat

doi:10.4274/jcrpe.521

Association Between Apolipoprotein E Polymorphism and Subclinic Atherosclerosis in Patients with Type 1 Diabetes Mellitus

Atıf İçin Kopyala

Atabek M. E., Özkul Y., Eklioglu B. S., Kurtoglu S., Baykara M.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, cilt.4, sa.1, ss.8-13, 2012 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 4 Sayı: 1
Basım Tarihi: 2012
Doi Numarası: 10.4274/jcrpe.521
Dergi Adı: JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.8-13
Erciyes Üniversitesi Adresli: Evet

Özet

Objective: The most important cause of morbidity and mortality in type 1 diabetes mellitus (DM) is atherosclerosis. Apolipoprotein E (Apo E) polymorphism is accused of being the genetic risk factor for atherosclerosis. The aim of the present study was to determine which Apo E polymorphism was related to atherosclerosis in patients with type 1 DM.